US Broker Ratings

Personalis, Inc. (PSNL) Stock Analysis: A 52.51% Potential Upside in the Healthcare Sector

Personalis, Inc. (NASDAQ: PSNL) has captured investor attention with a promising potential upside of 52.51%, according to recent analyst targets. As a key player in the..

Oruka Therapeutics, Inc. (ORKA)

⚠️ No article content returned.

..

Nurix Therapeutics, Inc. (NRIX): Investor Outlook on the Biotech Stock with a 184.57% Potential Upside

Nurix Therapeutics, Inc. (NASDAQ: NRIX) stands out in the biotechnology sector with a compelling investment narrative, particularly for those interested in high-growth potential stocks. With a..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Potential Upside of Over 329% Captivates Investors

MeiraGTx Holdings plc (NASDAQ: MGTX) is drawing attention in the biotech investment community with a noteworthy potential upside of 329.10%. This clinical-stage gene therapy company, headquartered..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Strong Buy Ratings Suggest 105% Potential Upside

Maze Therapeutics, Inc. (MAZE), a promising player in the biotechnology sector, is capturing investor attention with its focus on small molecule precision medicines targeting renal, cardiovascular,..

EyePoint Pharmaceuticals, Inc. (EYPT): Investor Outlook on a Promising Biotech with 343.83% Upside Potential

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) stands out in the biotechnology sector, particularly for investors seeking opportunities in healthcare innovations. With a robust pipeline targeting serious retinal..

AngioDynamics, Inc. (ANGO) Stock Analysis: Eyeing a 56.67% Upside Potential Amidst Challenging Metrics

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, specializes in the development and marketing of medical technologies designed to treat peripheral vascular disease..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a Potential 431% Upside in the Biotech Sector

Upstream Bio, Inc. (NASDAQ: UPB) has captured the attention of investors with a remarkable potential upside of 431.19%, as indicated by its average target price of..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a 416% Potential Upside in Biotechnology

Prothena Corporation plc (NASDAQ: PRTA), an Ireland-based biotechnology firm, is making waves with its innovative approach to treating diseases caused by protein dysregulation. Despite recent market..

SI-BONE, Inc. (SIBN) Investor Outlook: Unpacking a 29.96% Potential Upside in the Medical Device Sector

SI-BONE, Inc. (NASDAQ: SIBN), a prominent player in the healthcare sector, is capturing the attention of investors with its innovative approach to addressing musculoskeletal disorders. As..

Syndax Pharmaceuticals, Inc. (SNDX): Analyst Ratings Signal a Potential 221.86% Upside for Investors

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to cancer treatment and promising analyst..

Immatics N.V. (IMTX) Stock Analysis: Uncovering a 163% Upside Potential in the Biotech Arena

For individual investors interested in the promising intersection of innovative cancer treatments and biotechnology, Immatics N.V. (NASDAQ: IMTX) presents a compelling opportunity. As a clinical-stage biopharmaceutical..

Emergent BioSolutions Inc. (EBS) Investor Outlook: Exploring a Potential 109% Upside

Emergent BioSolutions Inc. (NYSE: EBS) is capturing investor attention with a striking potential upside of nearly 109%, as analysts set an average target price of $13.50,..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: A Look at Its Promising 63.98% Upside Potential

Theravance Biopharma, Inc. (NASDAQ: TBPH) is a noteworthy player in the biotechnology sector, specifically within healthcare, with a strategic focus on developing and commercializing innovative treatments..

Stoke Therapeutics, Inc. (STOK): Analyst Ratings Signal a 130% Upside Potential

Stoke Therapeutics, Inc. (NASDAQ: STOK), based in Bedford, Massachusetts, is a promising player in the biotechnology sector, focusing on groundbreaking treatments for severe genetic diseases. By..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating a 66% Potential Upside in the Healthcare Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a promising player in the healthcare sector, is making waves with its innovative approach to medical devices, particularly in the..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 119% Potential Upside

Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, is capturing the attention of investors with its promising growth potential. With a..

Eton Pharmaceuticals (ETON) Stock Analysis: Exploring a Potential 56.8% Upside in the Healthcare Sector

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is capturing investor attention with a notable potential upside of 56.8% based on its current stock price of $18.92. The company,..

Weave Communications, Inc. (WEAV) Stock Analysis: Evaluating a Promising 47.78% Upside Potential

Investors with an eye on the tech-driven healthcare sector should take a closer look at Weave Communications, Inc. (NYSE: WEAV). This Lehi, Utah-based company is carving..

Celcuity Inc. (CELC) Stock Analysis: Uncovering a 163% Potential Upside in the Biotech Sector

Investors seeking opportunities in the biotechnology sector may find Celcuity Inc. (NASDAQ: CELC) an intriguing prospect. With a striking potential upside of 163.40%, Celcuity’s stock presents..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds